Maxim Group
http://www.maximgrp.com/Maxim Group is a financial services firm that provides investment banking, asset management, research, and sales & trading to a diverse range of corporate clients, institutional investors and high net worth individuals.
The firm’s research division uses fundamental research and a “bottom up” approach to making investment recommendations. Maxim’s research analysts focus on under-covered, small- to mid-cap names in a variety of sectors including healthcare, technology, retail and others.
View Older Stories View More Recent Stories
-
Needham Downgrades SEMrush Holdings, Inc (SEMR) to Hold
-
HCW Biologics raises $4 million through warrant exercise agreement
-
HCW Biologics Enters into $4.0 Million Warrant Inducement Priced At-the-Market Under Nasdaq Rules
-
StoneBridge Acquisition II Corporation Announces the Separate Trading of its Class A Ordinary Shares and Rights, Commencing November 21, 2025
-
Autonomix Medical raises $5 million in private placement
-
Autonomix Medical, Inc. Announces Pricing of $5.0 Million Private Placement Priced At The Market Under Nasdaq Rules
-
Eco-Growth Strategies, Inc. Engages Maxim Group LLC to assist with its Growth Strategy and Up-List to Nasdaq
-
Co-Diagnostics Reports Third Quarter 2025 Financial Results
-
BioRestorative Therapies Reports Third Quarter 2025 Financial Results and Provides Business Update
-
SuperCom partners with B2i Digital for investor outreach
-
SuperCom Ltd. Partners With B2i Digital as Featured Company to Expand Investor Awareness
-
VisionSys AI prices $12 million registered direct offering
-
VisionSys AI Inc. Announces Pricing of $12.0 Million Registered Direct Offering
-
Belite Bio, Inc, ADR (BLTE) PT Raised to $140 at Maxim Group
-
AmpliTech Group To Release Q3 – 2025 Earnings On November 14th Before Market Opening – Also Announces Investor’s Conference Call
-
WISeKey and Columbus Acquisition agree to merge satellite unit WISeSat
-
WISeKey International Holding AG (Nasdaq: WKEY) and Columbus Acquisition Corp. (Nasdaq: COLA) Execute Business Combination Agreement to Publicly List WISeKey’s Subsidiary WISeSat.Space Corp. Under T
-
BioNexus files $100 million shelf registration, $20 million ATM program
-
BioNexus Gene Lab Corp. Files $100 Million Shelf Registration and Establishes $20 Million At-the-Market Program to Advance Strategic Growth Opportunities
-
WISeKey and Columbus Acquisition execute merger for WISeSat spin-off
-
GenSight Biologics Announces Successful Fundraising Amounting to Nearly €2 Million
-
Co-Diagnostics hires Maxim Group for potential SPAC deal with CoSara unit
-
Co-Diagnostics Engages Maxim Group to Pursue SPAC Transaction for its Indian Joint Venture, CoSara Diagnostics Pvt. Ltd
-
Rubico prices $7.5 million public offering at $0.609 per unit
-
Rubico Announces Pricing of $7.5 Million Underwritten Public Offering
-
Maxim Group Starts SBC Medical Group (SBC) at Buy
-
Maxim Group Starts Arrive AI (ARAI) at Buy
-
AmpliTech Group To Release Q3 – 2025 Earnings On November 14th Before Market Opening - Also Announces Investor’s Conference Call
-
Maxim Group Downgrades Cero Therapeutics (CERO) to Hold
-
Trust Stamp completes $4.3 million warrant inducement transaction
-
Trust Stamp Enters into $4.3 Million Warrant Inducement Transaction
-
INmune Bio Inc. Announces Third Quarter 2025 Results and Provides Business Update
-
CEO of eXoZymes to Present at Spartan Capital Securities' Second Annual Investor Conference
-
Co-Diagnostics closes $7 million stock offering at $0.55 per share
-
Co-Diagnostics, Inc. Announces Closing of $7.0 Million Registered Direct Offering of Common Stock Priced At-The-Market Under Nasdaq Rules
-
Maxim Group Downgrades Ryde Group (RYDE) to Hold
-
Guardian Metal Resources PLC Announces Final Results
-
XTI Aerospace, Inc. (XTIA) PT Lowered to $3 at Maxim Group
-
Co-Diagnostics prices $7 million stock offering at $0.55 per share
-
Co-Diagnostics, Inc. Announces Pricing of $7.0 Million Registered Direct Offering of Common Stock Priced At-The-Market Under Nasdaq Rules
-
PetVivo Holdings, Inc. to Present at Spartan Capital Securities' Second Annual Investor Conference
-
BIO-key International raises $3.1 million through warrant exercise
-
BIO-key International Enters into $3.1 Million Warrant Inducement Transaction
-
SELLAS raises $31 million through warrant exercise by institutional investor
-
SELLAS Life Sciences Group Announces Exercise of Existing Warrants Held by a Current Institutional Investor for $31 Million in Gross Proceeds
-
Genenta Science prices $15 million share offering
-
Genenta Announces Pricing of $15.0 Million Registered Direct Offering of American Depositary Shares
-
Robin Energy prices $7.0 million registered direct offering
-
Robin Energy Ltd. Announces Pricing of $7.0 Million Registered Direct Offering
-
Rani Therapeutics raises $60.3 million in oversubscribed private placement

